Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a …
…, F Long, YF Mujadidi, EL Plested, S Provstgaard-Morys… - The Lancet, 2021 - thelancet.com
Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation. However, we have previously reported that heterologous …
mass COVID-19 immunisation. However, we have previously reported that heterologous …
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK …
…, R Payne, EL Plested, S Provstgaard-Morys… - The Lancet, 2022 - thelancet.com
Background Given the importance of flexible use of different COVID-19 vaccines within the
same schedule to facilitate rapid deployment, we studied mixed priming schedules …
same schedule to facilitate rapid deployment, we studied mixed priming schedules …
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 …
…, A Platt, KM Pollock, I Poulton, S Provstgaard-Morys… - The Lancet, 2021 - thelancet.com
Background COVID-19 vaccine supply shortages are causing concerns about compromised
immunity in some countries as the interval between the first and second dose becomes …
immunity in some countries as the interval between the first and second dose becomes …
[HTML][HTML] Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised …
…, M Cairns, S Provstgaard-Morys… - The Lancet Infectious …, 2022 - thelancet.com
Background Malaria is a leading cause of morbidity and mortality worldwide. We previously
reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified …
reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified …
[HTML][HTML] Safety and immunogenicity report from the com-COV study–a single-blind randomised non-inferiority trial comparing heterologous and homologous prime …
…, M Greenland, T Dinesh, S Provstgaard-Morys… - 2021 - papers.ssrn.com
Background: Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation, however we have previously reported that heterologous …
mass COVID-19 immunisation, however we have previously reported that heterologous …
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory …
…, ER Morey, S Provstgaard-Morys… - The Lancet …, 2022 - thelancet.com
Background Priming COVID-19 vaccine schedules have been deployed at variable intervals
globally, which might influence immune persistence and the relative importance of third-…
globally, which might influence immune persistence and the relative importance of third-…
[HTML][HTML] Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
…, FL Yoni, TM Sanre, SB Ouattara, S Provstgaard-Morys… - The Lancet, 2024 - thelancet.com
Background Recently, we found that a new malaria vaccine, R21/Matrix-M, had over 75%
efficacy against clinical malaria with seasonal administration in a phase 2b trial in Burkina Faso…
efficacy against clinical malaria with seasonal administration in a phase 2b trial in Burkina Faso…
T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire
…, F Pilataxi, E Plested, S Provstgaard-Morys… - MedRxiv, 2021 - medrxiv.org
AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine,
has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (…
has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (…
Indications of future performance of native and non-native adult oysters under acidification and warming
…, S Fletcher, S Provstgaard-Morys… - Marine environmental …, 2018 - Elsevier
Globally, non-native species (NNS) have been introduced and now often entirely replace
native species in captive aquaculture; in part, a result of a perceived greater resilience of NSS …
native species in captive aquaculture; in part, a result of a perceived greater resilience of NSS …
[HTML][HTML] Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study–A single-blind, randomised trial incorporating mRNA …
…, R Payne, EL Plested, S Provstgaard-Morys… - Journal of Infection, 2023 - Elsevier
Background Heterologous COVID vaccine priming schedules are immunogenic and effective.
This report aims to understand the persistence of immune response to the viral vectored, …
This report aims to understand the persistence of immune response to the viral vectored, …
